| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1780* | 2021 |
| Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study RA Evans, H McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ... The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021 | 476 | 2021 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 441* | 2021 |
| Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis CP Kovesdy, K Matsushita, Y Sang, NJ Brunskill, JJ Carrero, G Chodick, ... European heart journal 39 (17), 1535-1542, 2018 | 289 | 2018 |
| Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ... The Lancet Respiratory Medicine 10 (8), 761-775, 2022 | 287 | 2022 |
| Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies J Coresh, HJL Heerspink, Y Sang, K Matsushita, J Arnlov, BC Astor, ... The lancet Diabetes & endocrinology 7 (2), 115-127, 2019 | 258 | 2019 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 399 (10320), 143, 2022 | 233 | 2022 |
| Cardiovascular disease risk factors in chronic kidney disease: A systematic review and meta-analysis RW Major, MRI Cheng, RA Grant, S Shantikumar, G Xu, I Oozeerally, ... PloS one 13 (3), e0192895, 2018 | 231 | 2018 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 219 | 2022 |
| Effects of sacubitril/valsartan versus irbesartan in patients with chronic kidney disease: a randomized double-blind trial R Haynes, PK Judge, N Staplin, WG Herrington, BC Storey, A Bethel, ... Circulation 138 (15), 1505-1514, 2018 | 204 | 2018 |
| Inhibitors of 3-Hydroxy-3-Methylglutaryl–CoA Reductase Reduce Receptor-Mediated Endocytosis in Opossum Kidney Cells JE Sidaway, RG Davidson, F McTaggart, TC Orton, RC Scott, GJ Smith, ... Journal of the American Society of Nephrology 15 (9), 2258-2265, 2004 | 197 | 2004 |
| Stimulation of proximal tubular cell apoptosis by albumin-bound fatty acids mediated by peroxisome proliferator activated receptor-γ M Arici, R Chana, A Lewington, J Brown, NJ Brunskill Journal of the American Society of Nephrology 14 (1), 17-27, 2003 | 195 | 2003 |
| Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 190 | 2021 |
| Conversion of urine protein–creatinine ratio or urine dipstick protein to urine albumin–creatinine ratio for use in chronic kidney disease screening and prognosis: an … K Sumida, GN Nadkarni, ME Grams, Y Sang, SH Ballew, J Coresh, ... Annals of internal medicine 173 (6), 426-435, 2020 | 189 | 2020 |
| Proteinuria induces tubular cell turnover: A potential mechanism for tubular atrophy ME Thomas, NJ Brunskill, KPG Harris, E Bailey, JH Pringle, PN Furness, ... Kidney international 55 (3), 890-898, 1999 | 183 | 1999 |
| Fatty acids exacerbate tubulointerstitial injury in protein-overload proteinuria ME Thomas, KPG Harris, J Walls, PN Furness, NJ Brunskill American Journal of Physiology-Renal Physiology 283 (4), F640-F647, 2002 | 163 | 2002 |
| Socio-demographic heterogeneity in the prevalence of COVID-19 during lockdown is associated with ethnicity and household size: Results from an observational cohort study CA Martin, DR Jenkins, JS Minhas, LJ Gray, J Tang, C Williams, S Sze, ... EClinicalMedicine 25, 2020 | 154 | 2020 |
| Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, L Estcourt, L Peto, ... MedRxiv, 2021.03. 09.21252736, 2021 | 142 | 2021 |
| Activation of mitogenic pathways by albumin in kidney proximal tubule epithelial cells: implications for the pathophysiology of proteinuric states R DIXON, NJ BRUNSKILL Journal of the American Society of Nephrology 10 (7), 1487-1497, 1999 | 135 | 1999 |
| Cellular and physiological effects of C-peptide CE Hills, NJ Brunskill Clinical science 116 (7), 565-574, 2009 | 134 | 2009 |
